The Houston Texans‘ Joe Mixon injury saga continues to cloud the franchise’s offseason plans. After a disappointing 2025 campaign, Houston faces major questions about its offensive identity—and the uncertainty surrounding Mixon sits at the center of it all.
Following a promising 2024 season, expectations for the Texans soared. However, the offense stumbled late last year, failing to deliver the explosive production required for a legitimate Super Bowl run. As the dust settles, attention has shifted to a mysterious absence that left fans and analysts searching for answers.
Joe Mixon’s 2025 Season: A Complete Absence
When the Texans placed Joe Mixon on the reserve/non-football injury (NFI) list in August 2025, many assumed a routine injury update would soon follow. Instead, the situation grew more perplexing.
Mixon missed the entire season. The team declined to publicly disclose the exact nature of his condition. Typically, NFL teams provide at least a general timeline or injury classification. In this case, Houston remained notably tight-lipped.
In January, Texans general manager Nick Caserio addressed the media to clarify the situation. However, his remarks only deepened the intrigue. He emphasized that Mixon did nothing reckless off the field and described the injury as a “medical condition or situation” that failed to improve as expected. Caserio characterized it as a rare and unusual issue—something he claimed he had never encountered before.
Despite the explanation, clarity remained elusive.
What We Know About the Injury
Multiple reports later indicated that Mixon’s absence stemmed from a foot injury. Still, key details—such as how the injury occurred or its severity—remain undisclosed.
During the NFL Combine in Indianapolis, Caserio revisited the subject. This time, he confirmed that Mixon underwent surgery “in some capacity” during the season. Yet even that acknowledgment left critical questions unanswered.
According to Caserio, the situation remains fluid. He described it as a “moving target,” suggesting that both availability and long-term prognosis remain uncertain. From a roster management perspective, that uncertainty complicates Houston’s offseason planning.
In the NFL, durability and availability often dictate personnel decisions. When a player’s health outlook lacks definition, front offices typically prepare contingency plans. The Texans appear to be doing exactly that.
Texans’ Offense Struggled Without Mixon
Houston acquired Mixon in 2024 with championship aspirations in mind. The move paid early dividends. Mixon provided balance, physicality, and consistency in the backfield. His presence stabilized the offense and complemented the passing game.
However, without him in 2025, the Texans’ rushing attack lacked identity. December and January exposed those deficiencies. The offense failed to control tempo, struggled in short-yardage situations, and lacked the explosive plays that define elite units.
As a result, Houston’s Super Bowl ambitions faded.
Although injuries are part of football, losing a projected feature back for an entire season significantly alters an offensive blueprint. The Texans’ underperformance highlighted how central Mixon had become to their system.
Is Houston Preparing to Move On?
Now, the conversation shifts from recovery to roster strategy. According to KPRC 2’s Aaron Wilson, the Texans are widely expected to part ways with Mixon during the offseason. A potential release at the start of the new league year on March 11 would reportedly cost Houston $2 million.
From a financial standpoint, that figure is manageable. From a football standpoint, however, it signals a clear pivot.
Houston is expected to pursue a veteran running back in free agency while also evaluating options in the NFL Draft. One intriguing name linked to the Texans is Kenneth Walker, the Seattle Seahawks running back and Super Bowl LX MVP. If available, Walker would represent a dynamic addition capable of reshaping the backfield immediately.
Nevertheless, free agency always carries uncertainty. Contract value, medical evaluations, and scheme fit will determine how aggressively Houston pursues any target.
What’s Next for Joe Mixon?
Mixon’s NFL future remains unclear. If healthy, he could attract interest from teams seeking veteran depth and playoff experience. However, much depends on medical evaluations and how transparent the recovery process becomes in the coming months.
At just one year removed from a strong 2024 season, Mixon still possesses the résumé to contribute. Yet durability concerns often dictate market value for running backs, particularly in today’s cost-conscious NFL landscape.
For Houston, the priority centers on stability. The running-back room will almost certainly look different this spring. Whether through free agency, the draft, or both, the Texans appear determined to avoid repeating last season’s offensive uncertainty.
Final Thoughts
The Houston Texans’ Joe Mixon injury situation underscores how quickly momentum can shift in the NFL. One year after trading for a back expected to anchor a Super Bowl-caliber offense, the franchise now faces a pivotal decision about his future.
Until more medical clarity emerges, speculation will continue. What remains certain is this: Houston cannot afford another season of ambiguity at a critical offensive position.
The coming weeks may finally provide answers—but for now, the Texans’ backfield remains one of the league’s most compelling offseason storylines.